Jefferies analysts recently upgraded their rating on GE HealthCare (NASDAQ:GEHC) Technologies Inc. to "buy" from "hold," reflecting a more optimistic outlook for the company. Shares of the medical technology company were up 1.

Fintel reports that on January 8, 2025, Jefferies upgraded their outlook for GE HealthCare Technologies (NasdaqGS:GEHC) from Hold to Buy. Analyst Price Forecast Suggests 18.70% Upside As of December 23,

Jefferies has upgraded GE Healthcare Technologies (NASDAQ:GEHC) to buy from hold citing the company's recent pullback in share price and expected growth in several areas of business. The investment bank raised its target price to $103 from $95 (~24% upside based on Jan.

Jefferies believes aggressive moves by incumbents and entry of new players in the QC space can result in higher discounting which may pose a threat to the company's profits in the medium term.

Fintel reports that on January 7, 2025, William Blair downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Outperform to Market Perform. Analyst Price Forecast Suggests 14.20% Downside As of December 23,